Amanda L. Rose

206-389-4553
arose@fenwick.com
Practice Area Co-Lead
Capital Markets , Public Companies
Partner
Corporate

Amanda L.
Rose

Amanda L.
Rose

Amanda L.
Rose

Partner
Corporate
Practice Area Co-Lead
Capital Markets,
Public Companies
Industries

Amanda is a recognized, focused and innovative leader in the capital markets and life sciences space.

She advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, SPACs, at-the-market offerings, private investment in public equity (PIPEs), and preferred stock and debt financings.

Amanda also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements.

Chambers USA ranks Amanda as a top capital markets lawyer. In 2024, Amanda was highlighted by The Legal 500 as among the leading lawyers in U.S. capital markets and healthcare: life sciences.

Amanda is an exceptional attorney and adviser who can tackle the most complex of matters."

Chambers USA, Client Quote

2023 Edition

  • Achieve Life Sciences
  • Adaptive Biotechnologies
  • Aeglea BioTherapeutics
  • AnaptysBio
  • Audentes Therapeutics
  • BioPharmX
  • Cascadian Therapeutics
  • Chegg
  • Facebook
  • King Digital Entertainment
  • LendingClub
  • Meru Networks
  • Model N
  • Morphic Therapeutic
  • Nurix Therapeutics
  • Obalon Therapeutics
  • Sierra Oncology
  • Sutro Biopharma
  • Tableau Software
  • Trupanion
  • Vocera Communications

  • Achieve Life Sciences
  • Adaptive Biotechnologies
  • Aeglea BioTherapeutics
  • AnaptysBio
  • Audentes Therapeutics
  • BioPharmX
  • Cascadian Therapeutics
  • Chegg
  • Facebook
  • King Digital Entertainment
  • LendingClub
  • Meru Networks
  • Model N
  • Morphic Therapeutic
  • Nurix Therapeutics
  • Obalon Therapeutics
  • Sierra Oncology
  • Sutro Biopharma
  • Tableau Software
  • Trupanion
  • Vocera Communications

  • Achieve Life Sciences
  • Aeglea BioTherapeutics
  • Amyris
  • AnaptysBio
  • Audentes Therapeutics
  • BioPharmX
  • Castlight Health
  • Chinook Therapeutics
  • CohBar
  • Energous
  • Goldman Sachs
  • Graybug Vision
  • Impel NeuroPharma
  • JPMorgan
  • KalVista
  • Lyell Immunopharma
  • Marin Software
  • Model N
  • Morphic Therapeutic
  • Nautilus
  • Neoleukin Therapeutics
  • Nurix Therapeutics
  • Sierra Oncology
  • Sutro Biopharma
  • Trupanion
  • Vocera Communications
  • Vulcan

  • Achieve Life Sciences
  • Aeglea BioTherapeutics
  • Amyris
  • AnaptysBio
  • Audentes Therapeutics
  • BioPharmX
  • Castlight Health
  • Chinook Therapeutics
  • CohBar
  • Energous
  • Goldman Sachs
  • Graybug Vision
  • Impel NeuroPharma
  • JPMorgan
  • KalVista
  • Lyell Immunopharma
  • Marin Software
  • Model N
  • Morphic Therapeutic
  • Nautilus
  • Neoleukin Therapeutics
  • Nurix Therapeutics
  • Sierra Oncology
  • Sutro Biopharma
  • Trupanion
  • Vocera Communications
  • Vulcan

Recognition Recognition Recognition

Recognition Recognition Recognition

Recognition
Chambers USA

2023-2024

Chambers USA ranked Amanda as a leading lawyer in Capital Markets: Debt & Finance in California and the Western United States.

Chambers Global and Chambers USA

2019-2021

Recognized Amanda as a leading lawyer in Capital Markets: Debt & Equity in the Western United States

The Legal 500

2020 & 2022-2023

Listed Amanda among the leading lawyers in U.S. Capital Markets: Equity Offerings

LMG Life Sciences

2019

Included Amanda on its shortlist for U.S. Rising Star Financial & Corporate

Recognition
Chambers USA

2023-2024

Chambers USA ranked Amanda as a leading lawyer in Capital Markets: Debt & Finance in California and the Western United States.

Chambers Global and Chambers USA

2019-2021

Recognized Amanda as a leading lawyer in Capital Markets: Debt & Equity in the Western United States

The Legal 500

2020 & 2022-2023

Listed Amanda among the leading lawyers in U.S. Capital Markets: Equity Offerings

LMG Life Sciences

2019

Included Amanda on its shortlist for U.S. Rising Star Financial & Corporate